Detalles de la búsqueda
1.
Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.
Antioxidants (Basel)
; 11(2)2022 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35204103
2.
HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons.
Front Pharmacol
; 11: 621054, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33584306
3.
Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3'-diindolylmethane and chemotherapy drugs.
Biochimie
; 179: 217-227, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098909
4.
"Branched Tail" Oxyquinoline Inhibitors of HIF Prolyl Hydroxylase: Early Evaluation of Toxicity and Metabolism Using Liver-on-a-chip.
Drug Metab Lett
; 13(1): 45-52, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488807
5.
Which cytochrome P450 metabolizes phenazepam? Step by step in silico, in vitro, and in vivo studies.
Drug Metab Pers Ther
; 33(2): 65-73, 2018 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29727298
6.
Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.
ACS Chem Neurosci
; 9(5): 894-900, 2018 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29338172
Resultados
1 -
6
de 6
1
Próxima >
>>